Electronic Prompts for Type 2 Diabetes
(DEPICCT Trial)

Recruiting in Palo Alto (17 mi)

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Rutgers, The State University of New Jersey

No Placebo Group

Trial Summary

What is the purpose of this trial?

The goal of this clinical trial is to improve the processes of Type 2 Diabetes (T2D) care coordination and treatment in the emergency department (ED) by utilizing clinical decision support mechanisms in the electronic health record (EHR). The main question is whether electronic prompts triggered by hyperglycemia and elevated A1c results in providers providing earlier treatments and faster time to subsequent primary care appointment and greater reduction in hemoglobin A1c (HA1c). ED clinicians will receive alerts called Our Practice Advisories (OPA's) through the EPIC EHR. The 1st OPA triggers when a random point-of-care (POC) glucose is ≥250 mg/dL, prompting a suggested additional HA1c order. A 2nd OPA triggers if the resulting HA1c is ≥10%, prompting consideration of further care coordination in the Observation Unit. Investigators will compare the outcomes between the two groups: hyperglycemia electronic prompt alerts vs no alerts.

Research Team

Eligibility Criteria

This trial is for individuals with Type 1 or Type 2 Diabetes who visit the emergency department. It's designed to see if electronic prompts in the hospital's record system can help doctors spot and treat high blood sugar faster.

Inclusion Criteria

Moderate hyperglycemia (glucose ≥250 mg/dL)

Patients who arrive in the emergency department

Not pregnant or peri-partum

See 1 more

Exclusion Criteria

Diabetic ketoacidosis (pH < 7.20, HCO3 < 15, AG > 25)

Patients who leave against medical advice (AMA), elope from the ED, or are transferred to another facility

I have a diabetic foot ulcer or skin issues due to diabetes.

See 1 more

Treatment Details

Interventions

Diabetes Electronic Prompt (Behavioural Intervention)

Trial OverviewThe study tests whether alerts (OPAs) for high glucose levels lead to quicker additional testing, better care coordination, and improved diabetes control. One alert suggests more tests when glucose is very high; another recommends extra care steps if A1c is extremely elevated.

Participant Groups

2Treatment groups

Experimental Treatment

Active Control

Group I: Week ONExperimental Treatment2 Interventions

ED Providers will receive electronic prompts

Group II: Week OFFActive Control1 Intervention

No electronic prompt alert visible to ED providers